Dr. Wambui Wamburu
The Drug Chat with Dr. Wambui
Dr. Wambui provides drug education using simple terms. Drugs will always be in our lives, let’s get empowered through knowledge to be better healthcare providers, caregivers, or patients.
Não deixe de visitar o site do podcast e apoiar quem o produz: podcasters.spotify.com
Autor
Dr. Wambui Wamburu
Categoria
Site do podcast
Último episódio
8 de jun de 2026
Onde ouvir?
Podcasts no app Replaio Radio Em breveOs podcasts estão chegando ao app. Instale agora e seja o primeiro a descobrir um jeito totalmente novo de curtir podcasts
Instale grátis
Android 5 mi+ downloads · nota 4,8
iOS em breve
Episódios
Anthracylines and Platinum Compounds 25.10.2021 18:04
We are at the tail end of the traditional chemotherapies. Yippee! The mechanism of action of these two classes, with associated toxicities and pharmacokinetics are discussed in this episode. As always we apply concepts of pharmacology to better learn and retain how the drugs work.
Antimetabolites and Topoisomerase Inhibitors 18.10.2021 15:16
Our journey continues with another 2 classes of anticancer drugs. Looking at how they plug into our bodies, plus we use examples of the drugs in these classes for better understanding.
Alkylating Agents 12.10.2021 10:45
An overview on these drugs' mechanism of action, possible toxicities and drug interactions.
Basics of How drugs work 12.10.2021 15:13
In this episode we travel with the drug through your body and simplify different terms used in Pharmacology.
The Cell Cycle 01.10.2021 12:36
In this season we will chat about Anti-cancer drugs. To better understand them we need to look at where it all goes down, the site of action. This episode gives an overview of what happens in the cell so as to make drug application easier.
Podcasts parecidos
Ouça o podcast The Drug Chat with Dr. Wambui no Replaio
Rádio e podcasts em um só app - grátis e sem cadastro. Instale hoje e não perca o lançamento
O Replaio não é o publicador dos podcasts; os nomes dos programas, as capas e o áudio pertencem aos seus autores e são distribuídos por feeds RSS públicos
